Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2009

View Archived Issues

New Aurora B kinase inhibitors reported in recent Boehringer Ingelheim patent

New mGluR1 and mGluR5 receptor ligands discovered at Gedeon Richter

AstraZeneca identifies novel CRTh2 receptor ligands for respiratory disorders

Novel selective AT2 receptor agonists disclosed by Mitsubishi Tanabe

NVP-BEZ-235 a candidate for ovarian cancer treatment

Novel PDF inhibitors prepared and tested at Il-Dong

Novartis presents fourth quarter highlights

Phase II results for temozolomide in non-small cell lung cancer reported

Toxicity seen with everolimus/tacrolimus regimen in stem cell transplant patients

Prolonged dosing of TLR-7 agonist 852A assessed in cancer patients

Transition Therapeutics completes patient enrollment of phase II TT-223 study

Cytopia successfully concludes phase I oral CYT-997 trial

Raptor completes enrollment in phase IIa nonalcoholic steatohepatitis trial

Adventrx completes enrollment in ANX-514 bioequivalence study

BioDelivery Sciences presents initial phase I Bioral amphotericin B results

King offers new dosage strengths of Avinza for chronic pain

Trial aimed at regenerating insulin-producing capacity gets FDA approval

Oncolys initiates French phase Ib clinical study of Festinavir in HIV patients

Favrille changes name to MMR Information Systems

Oncolytics and the CTRC at UTHSCSA enter collaboration for phase II studies of Reolysin

GlaxoSmithKline and Genmab seek E.U. marketing authorization for Arzerra

Dyax expands antibody discovery collaboration with Biogen

Immunomedics' hPAM4 labeled with yttrium-90 receives fast track designation

Partnership aims to develop proof-of-concept vaccine against Chikungunya virus

UCB meets with FDA to define Cimzia regulatory path in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...